DGFT Minutes
In force — no superseding record on file.
Government of India Ministry of Commerce and Industry Department of Commerce DIRECTORATE GENERAL OF FOREIGN TRADE
Minutes of the Norms Committee – 3 Meeting No. NC/3/MEET/Jun/202324/06 dated 14/06/2023 (actual held on 21/06/2023) under the Chairmanship of Shri Rajiv Kumar Soni, Jt. DGFT for considering the 26 Advance Authorizations issued to M/s Jodas Expoim Pvt. Ltd., New Delhi under Duty Exemption Scheme (Chapter-4) of Foreign Trade Policy, 2023 pertaining to Chemical and Allied products falling under Chapter 29 and 30.
Following members were present in the Meeting:
| Sl.<br>No. | Name & Designation | Department |
|---|---|---|
| (i) | Shri D.N. Mathur, Technical–1 | Consultant |
| (ii) | Shri Shaish Kumar, Technical–2 | Consultant |
| (iii) | Shri Nand Lal, Technical–3 | Consultant |
| In attendance: | ||
| 1 | Shri T. Songzalian, Deputy DGFT | DGFT |
- The Norms Committee has taken decision only with respect to technical aspect/ wastage norms. While redeeming the application, RAs should check that the applicant has fulfilled all requirements as prescribed in policy/procedure including those in policy circulars issued from time to time or any other provisions under FTP/HBP for issuance of Advance Authorization and regularization of the case.
escribed in policy/procedure including those in policy circulars issued from time to time or any other provisions under FTP/HBP for issuance of Advance Authorization and regularization of the case.
| Case No. | A-01 |
|---|---|
| Meeting No. | NC/3/MEET/Jun/202324/6 |
| Date | 14/06/2023 |
| Firm’s Name | M/s Jodas Expoim Private Limited |
| Subject | The fixation of norms in respect of 26 advance authorizations issued<br>to M/s Jodas Expoim Pvt. Ltd, New Delhi under Para 4.07 of HBP<br>Vol.1. |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP of 26 advance authorizations issued to M/s Jodas Expoim Pvt. Ltd, New Delhi.
| Case No. 01 | Party Name: | Meet No & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No & Date: | Approved | |||
| 01/82/050/01834/AM19/ | 05/23/040/00081/AM19/ | No. 0510406732 | ||||
| dated: 05.06.2018 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
e as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Case No. 01 | Party Name:<br>JODAS EXPOIM PVT.LTD | Meet No & Date:<br>No. NC/3/MEET/Jun/202324/6<br>Dated: 14/06/2023 | Status:<br> | |
|---|---|---|---|---|
| HQ File No.<br>01/82/050/01834/AM19/ | <br>RLA File No.<br>05/23/040/00081/AM19/ | Lic. No & Date:<br>No. 0510406732<br>dated: 05.06.2018 | Approved | |
| **Decision:**The Committee considered case as per agenda in the presence of the technical experts and it was<br>decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm<br>whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Total Qty.<br>PACLITAXEL INJECTION USP<br>30mgI/ml. 5 ml/ Vial ( Net weight of<br>export product 1.653 Kgs)<br>Nil<br>1<br>Relevant Bulk Drug<br>PACLITAXEL USP<br>( Import& Export<br>Governed by PC 9 Dated<br>30.06.2003 as amended)<br>Clear, colorless to pale<br>yellowliquid.<br>6.10 kg.<br>PACLITAXEL INJECTION USP<br>100mgI/ml. 16.67ml / Vial ( Net weight<br>of export product 2.893 Kgs)<br>22841<br>Numbers<br>1<br>Relevant Bulk Drug<br>PACLITAXEL USP<br>( Import& Export<br>Governed by PC 9 Dated<br>30.06.2003 as amended)<br>Clear, colorless to pale<br>yellow liquid.<br>PACLITAXEL INJECTION USP 260<br>mgI/ml. |
r>Relevant Bulk Drug<br>PACLITAXEL USP<br>( Import& Export<br>Governed by PC 9 Dated<br>30.06.2003 as amended)<br>Clear, colorless to pale<br>yellow liquid.<br>PACLITAXEL INJECTION USP 260<br>mgI/ml. 43.4ml / Vial ( Net weight of<br>export product 0.827 Kgs)<br>5050<br>Numbers<br>1<br>Relevant Bulk Drug<br>PACLITAXEL USP<br>( Import& Export<br>Governed by PC 9 Dated<br>30.06.2003 as amended)<br>Clear, colorless to pale<br>yellow liquid.<br>PACLITAXEL INJECTION USP<br>300mgI/ml. 50 ml / Vial ( Net weight of<br>export product 2.892 Kgs)<br>7494<br>Numbers<br>1<br>Relevant Bulk Drug<br>PACLITAXEL USP<br>( Import& Export<br>Governed by PC 9 Dated<br>30.06.2003 as amended)<br>Clear, colorless to pale<br>yellow liquid.<br>RA concerned maytake further necessaryaction asper above decision of NC.||||
RA concerned may take further necessary action as per above decision of NC.
| Case No. 02 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No: | Lic. No & Date: | Approved | |||
| 01/82/050/02074/AM19/ | 05/23/040/00166/AM19/ | No. 0510407070 | ||||
| Dated: 04.07.2018 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
er agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
| Export product<br>GEMCITABINE FOR INJECTION<br>1000MG. Import & Export to be<br>Governed as per Policy Circular 9 dated<br>30.06.2003 as amended.<br>GEMCITABINE FOR INJECTION<br>200MG. Import & Export to be Governed<br>as per Policy Circular 9 dated 30.06.2003<br>as amended. | Qty. | Sl.<br>No. | Import items | Total Qty. |
|---|---|---|---|---|
| 31194<br>Numbers | 1 | GEMCITABINE HCL.<br>Relevant Bulk Drug<br>Import & Export to be<br>Governed as per Policy<br>Circular 9 dated<br>30.06.2003 as amended | 43.40 kg. | |
| 25297<br>Numbers | 1 | GEMCITABINE HCL.<br>Relevant Bulk Drug<br>Import & Export to be<br>Governed as per Policy<br>Circular 9 dated<br>30.06.2003 as amended |
RA concerned may take further necessary action as per above decision of NC.
| Case No. 03 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD. | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No. & Date: | Approved | |||
| 01/82/050/01876/AM19/ | 05/23/040/00164/AM19/ | No. 0510407078 | ||||
| Dated 04.07.2018 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
er agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
| Export product<br>TIGECYCLIN FOR INJECTION USP<br>50MG / VIAL (LYOPHILIZED). | Qty. | Sl.<br>No. | Import items | Qty. |
|---|---|---|---|---|
| 27375<br>Numbers | 1 | TIGECYCLINE. | 1.4372 kg. |
RA concerned may take further necessary action as per above decision of NC.
| Case No.04 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD. | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No. & Date: | Approved | |||
| 01/82/050/01842/AM19/ | 05/23/040/00501/AM18/ | No. 0510406802 | ||||
| Dated: 08.06.2018 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
| Export product | Qty. | Sl.<br>No. | Import items | Qty. |
|---|---|---|---|---|
| TIGECYCLINE FOR INJECTION USP<br>50 MG/ VIAL (LYOPHILIZED) | 107420<br>Numbers | 1 | TIGECYCLINE | 5.00 kg. |
RA concerned may take further necessary action as per above decision of NC.
---|---|---|---| |TIGECYCLINE FOR INJECTION USP<br>50 MG/ VIAL (LYOPHILIZED)|107420<br>Numbers|1|TIGECYCLINE|5.00 kg.|
RA concerned may take further necessary action as per above decision of NC.
| Case No. 06 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT. LTD. | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No & Date: | Approved | |||
| 01/82/050/00646/AM19/ | 05/23/040/00214/AM19/ | No. 0510407421 | ||||
| Dated: 02.08.2018 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
| Export Product | Qty. | Sl.<br>No. | Import items | Qty. |
|---|---|---|---|---|
| Eptifibatide Injection 2mg/ml<br>(10ml fill) Import & Export to<br>be governed as per Policy<br>Circular no. 9 dated<br>30.06.2003 as amended. | 10090<br>Numbers | 1 | EPTIFIBATIDE<br>Relevant Bulk Drug. | 1.197 kg. |
| Eptifibatide Injection<br>75mg/100mL (0.75mg/mL)<br>Import & Export to be<br>governed as per Policy Circular<br>no. 9 dated 30.06.2003 as<br>amended. | 12375<br>Numbers |
t Bulk Drug.|1.197 kg.| |Eptifibatide Injection<br>75mg/100mL (0.75mg/mL)<br>Import & Export to be<br>governed as per Policy Circular<br>no. 9 dated 30.06.2003 as<br>amended.|12375<br>Numbers||||
| Case No. 07 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT. LTD. | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No. & Date: | Approved | |||
| 01/82/050/02027/AM19/ | 05/23/040/00295/AM19/ | No. 0510408025 | ||||
| Dated: 08.10.2018 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
| Export Product | Qty. | Sl. | Import items | Qty. | |
|---|---|---|---|---|---|
| No. | |||||
| VANCOMYCIN HCL 1GRAM<br>(VANCOMYCIN DJ -1GRAM)<br>INJECTION VIAL - Drug. | 324977<br>Numbers | 1 | VANCOMYCIN HCL EP<br>STERILE<br>RELEVANT<br>BULK DRUG. | 350 kg. | |
| VANCOMYCIN HCL 500MG | Nil | ||||
| (VANCOMYCIN DJ -500MG) | |||||
| INJECTION<br>VIAL | |||||
| Net<br>Weight<br>of<br>Export<br>Item | |||||
| 132.392KG. |
| Case No. 08 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT. LTD. | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No. & Date: | Approved | |||
| 01/82/050/01889/AM19/ | 05/23/040/00183/AM19/ | No. 0510407217 | ||||
| Dated: 17.07.2018 |
4/6||| |||||Dated: 14/06/2023||| |HQ File No.||RLA File No.||Lic. No. & Date:||Approved| |01/82/050/01889/AM19/||05/23/040/00183/AM19/||No. 0510407217||| |||||Dated: 17.07.2018|||
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
| Sl. | Export Product | Export Product | Quantity in |
|---|---|---|---|
| No | Numbers | ||
| 1 | IOPAMIDOL(612.34mg/ml)Injection. 300mgI/ml. 30ml Vial. | Nil | |
| 2 | IOPAMIDOL(612.34mg/ml)Injection. 300mgI/ml. 50ml Vial. | Nil | |
| 3 | IOPAMIDOL(612.34mg/ml)Injection. 300mgI/ml. 100ml Vial. | 3925 | |
| 4 | IOPAMIDOL(755.22mg/ml)Injection. 370mgI/ml. 30ml Vial. | Nil | |
| 5 | IOPAMIDOL(755.22mg/ml)Injection. 370mgI/ml. 50ml Vial. | 16750 | |
| 6 | IOPAMIDOL(755.22mg/ml)Injection. 370mgI/ml. 100ml Vial. | 13700 | |
| Sl. | Import Item | Quantity | |
| No. | allowed | ||
| 1 | IOPAMIDOL USP.Relevant Bulk | 2000 Kg. |
Case No. 09 Party Name: Meet No. & Date: Status: JODAS EXPOIM PVT.LTD No. NC/3/MEET/Jun/202324/6 Dated: 14/06/2023 HQ File No. RLA File No. Lic. No & Date: Approved 01/82/050/02145/AM19/ 05/23/040/00385/AM19/ No.0510408748 Dated: 04.12.2018
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
er agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
| Sl.<br>No | Export Product | Export Product | Quantity in<br>Numbers |
|---|---|---|---|
| 1 | IOPAMIDOL (612.34mg/ml) Injection. 300mgI/ml. 30ml Vial. | Nil | |
| 2 | IOPAMIDOL (612.34mg/ml) Injection. 300mgI/ml. 50ml Vial. | Nil | |
| 3 | IOPAMIDOL (612.34mg/ml) Injection. 300mgI/ml. 100ml Vial. | 2400 | |
| 4 | IOPAMIDOL (755.22mg/ml) Injection. 370mgI/ml. 30ml Vial. | Nil | |
| 5 | IOPAMIDOL (755.22mg/ml) Injection. 370mgI/ml. 50ml Vial. | 5000 | |
| 6 | IOPAMIDOL (755.22mg/ml) Injection. 370mgI/ml. 100ml Vial. | 4175 | |
| Sl.<br>No. | Import Item | Quantity<br>allowed | |
| 1 | IOPAMIDOL USP. Relevant Bulk | 683.38 kg. |
Case No. 10 Party Name: Meet No & Date: Status: JODAS EXPOIM PVT.LTD No. NC/3/MEET/Jun/202324/6 Dated: 14/06/2023 HQ File No. RLA File No. Lic. No & Date: Approved 01/82/050/01836/AM19/ 05/23/040/00070/AM19/ No. 0510406734 Dated: 05.06.2018
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
er agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
| Export Product | Qty. | Sl.<br>No. | Import items | Qty. |
|---|---|---|---|---|
| IOHEXOL<br>300<br>MG<br>I/ML<br>SOLUTION FOR INJECTION<br>647 MG/300 MGI /50 ML VIAL | 16770<br>Numbers | 1 | Relevant Bulk Drug IOHEXOL | 1800 kg. |
| IOHEXOL<br>350<br>MG<br>I/ML<br>SOLUTION FOR INJECTION<br>755 MG/350 MGI /50 ML VIAL | 31109<br>Numbers |
| Case No. 11 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT. LTD. | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No. & Date: | Approved | |||
| 01/82/050/02067/AM19/ | 05/23/040/00334/AM19/ | No. 0510408268 | ||||
| Dated: 30.10.2018 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export product | Qty. | Sl.<br>No. | Import items | Total Qty. |
|---|---|---|---|---|
| Cefuroxime Sodium For Injection<br>750mg. | 245389<br>Numbers | 1 | CEFUROXIME<br>SODIUM RELEVANT<br>BULK DRUG | 600 kg. |
| Cefuroxime Sodium For Injection<br>1.5g. | 224220<br>Numbers | 1 | CEFUROXIME<br>SODIUM RELEVANT<br>BULK DRUG |
RA may take appropriate action as per the decision of Norms Committee
ULK DRUG|600 kg.| |Cefuroxime Sodium For Injection<br>1.5g.|224220<br>Numbers|1|CEFUROXIME<br>SODIUM RELEVANT<br>BULK DRUG||
RA may take appropriate action as per the decision of Norms Committee
| Case No. 12 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD. | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No & Date: | Approved | |||
| 01/82/050/01795/AM19/ | 05/23/040/00348/AM18/ | No. 0510404882 | ||||
| Dated: 12.12.2017 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
| Export Product | Qty. | Sl.No. | Import items | Qty. |
|---|---|---|---|---|
| Cefuroxime Sodium For<br>Injection 1.50 GRAM. | 86898<br>Numbers | 1 | CEFUROXIME SODIUM | 150 kg. |
| Case No. 13 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No & Date: | Approved | |||
| 01/82/050/01874/AM19/ | 05/23/040/00167/AM19/ | No. 0510407069 | ||||
| Dated: 04.07.2018 |
24/6||| |||||Dated: 14/06/2023||| |HQ File No.||RLA File No.||Lic. No & Date:||Approved| |01/82/050/01874/AM19/||05/23/040/00167/AM19/||No. 0510407069||| |||||Dated: 04.07.2018|||
| Case No. 13 | Case No. 13 | Case No. 13 | Party Name:<br>JODAS EXPOIM PVT.LTD<br> <br>RLA File No.<br>05/23/040/00167/AM19/ | Meet No. & Date:<br>No. NC/3/MEET/Jun/202324/6<br>Dated: 14/06/2023 | Meet No. & Date:<br>No. NC/3/MEET/Jun/202324/6<br>Dated: 14/06/2023 | Status: | |
|---|---|---|---|---|---|---|---|
| HQ File No.<br>01/82/050/01874/AM19/ | Lic. No & Date:<br>No. 0510407069<br>Dated: 04.07.2018 | Approved | |||||
| **Decision:**The Committee considered case as per agenda in the presence of the technical experts and it was<br>decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by<br>firm whichever is lower:<br>Sl.<br>No<br>Export Product<br>Quantity in<br>Numbers<br>1<br>DRUG FORMULATIONS INJECTIONS/ AMPULES/VIALS. GADODIAMIDE<br>INJECTION USP 10ml Vial.<br>4990<br>2<br>DRUG FORMULATIONS INJECTIONS/ AMPULES/VIALS .GADODIAMIDE<br>INJECTION USP 15mlVial.<br>5120<br>3<br>DRUG FORMULATIONS INJECTIONS/ AMPULES/VIALS. |
ADODIAMIDE<br>INJECTION USP 10ml Vial.<br>4990<br>2<br>DRUG FORMULATIONS INJECTIONS/ AMPULES/VIALS .GADODIAMIDE<br>INJECTION USP 15mlVial.<br>5120<br>3<br>DRUG FORMULATIONS INJECTIONS/ AMPULES/VIALS. GADODIAMIDE<br>INJECTION USP 20ml Vial.<br>19210<br>Sl.<br>No.<br>Import Item<br>Total<br>Quantity<br>1<br>GADODIAMIDE USP.<br>154.676 kg.<br>2<br>CALDIAMIDE SODIUM<br>6.467 kg.<br>RA concerned maytake further necessaryaction asper above decision of NC.||||||| ||Sl.<br>No|Export Product||||Quantity in<br>Numbers|| ||1|DRUG FORMULATIONS INJECTIONS/ AMPULES/VIALS. GADODIAMIDE<br>INJECTION USP 10ml Vial.||||4990|| ||2|DRUG FORMULATIONS INJECTIONS/ AMPULES/VIALS .GADODIAMIDE<br>INJECTION USP 15mlVial.||||5120|| ||3|DRUG FORMULATIONS INJECTIONS/ AMPULES/VIALS. GADODIAMIDE<br>INJECTION USP 20ml Vial.||||19210|| ||||||||| ||Sl.<br>No.||Import Item|||Total<br>Quantity|| ||1||GADODIAMIDE USP.|||154.676 kg.|| ||2||CALDIAMIDE SODIUM|||6.467 kg.|| ||RA concerned maytake further necessaryaction asper above decision of NC.|||||||
| Case No.14 | Party Name: | Meet No & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No & Date: | Approved | |||
| 01/82/050/01998/AM19/ | 05/23/040/00282/AM19/ | No. 0510407958 | ||||
| Dated: 03.10.2018 |
4/6||| |||||Dated: 14/06/2023||| |HQ File No.||RLA File No.||Lic. No & Date:||Approved| |01/82/050/01998/AM19/||05/23/040/00282/AM19/||No. 0510407958||| |||||Dated: 03.10.2018|||
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export product | Qty. | Sl.No. | Import items | Total Qty. |
|---|---|---|---|---|
| Oxaliplatin Concentrate for<br>Preparation of solution for<br>Infusion (IV) 2 mg/mL,<br>25mL/Vial. | 24630<br>Numbers | 1 | OXALIPLATIN EP<br>RELEVANT BULK<br>DRUG. | 3.00 kg. |
| Oxaliplatin Concentrate for<br>Preparation of solution for Infusion<br>(IV)2 mg/mL,50mL/Vial. | 16410<br>Numbers |
RA may take appropriate action as per the decision of Norms Committee.
| Case No. 15 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No. & Date: | Approved | |||
| 01/82/050/01802/AM19/ | 05/23/040/00377/AM18/ | No. 0510405191 | ||||
| Dated: 02.01.2018 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
e as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export product | Qty. | Import items | Qty. |
|---|---|---|---|
| Capecitabine Tablets USP 500mg | 373000<br>Numbers | CAPECITABINE | 190 kg. |
| Case No. 16 | Party Name: | Meet No & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT. LTD. | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No. & Date: | Approved | |||
| 01/82/050/01971/AM19/ | 05/23/040/00259/AM19/ | No. 0510407799 | ||||
| Dated: 17.09.2018 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Qty. | Import items | Qty. |
|---|---|---|
| 1338520<br>Numbers | CAPECITABINE RELEVANT<br>BULK DRUG | 682.645 kg. |
RA may take appropriate action as per the decision of Norms Committee.
| Case No. 18 | Party Name: | Meet No & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File | RLA File :05/23/040/00260/AM19/ | Lic. No. & Date: | Approved | |||
| 01/82/050/01970/AM19/ | No. 0510407798 | |||||
| Dated: 17.09.2018 |
/MEET/Jun/202324/6||| |||||Dated: 14/06/2023||| |HQ File||RLA File :05/23/040/00260/AM19/||Lic. No. & Date:||Approved| |01/82/050/01970/AM19/||||No. 0510407798||| |||||Dated: 17.09.2018|||
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Sl. No | Export Product | Quantity in |
|---|---|---|
| Numbers | ||
| 1 | Ampicillin & Sulbactam for Injection 375mg. Import & Export to | 117800 |
| be governed as per P/C 9 dated 30.06.2003 as amended | ||
| 2 | Ampicillin & Sulbactam for Injection 750mg. Import & Export to | 145975 |
| be governed as per P/C 9 dated 30.06.2003 as amended | ||
| 3 | Ampicillin & Sulbactam for Injection 1500mg. Import & Export | 1233019 |
| to be governed as per P/C 9 dated 30.06.2003 as amended | ||
| Sl. | Import Item | Quantity |
| No. | allowed | |
| 1 | SULBACTUM SODIUM RELEVANT BULK DRUG | 800 kg. |
RA may take appropriate action as per the decision of Norms Committee.
| Case No. 19 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No. & Date: | Approved | |||
| 01/82/050/01927/AM19/ | 05/23/040/00232/AM19/ | No. 0510407550 | ||||
| Dated: 20.08.2018 |
/6||| |||||Dated: 14/06/2023||| |HQ File No.||RLA File No.||Lic. No. & Date:||Approved| |01/82/050/01927/AM19/||05/23/040/00232/AM19/||No. 0510407550||| |||||Dated: 20.08.2018|||
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
| Sl. No | Export Product | Quantity in |
|---|---|---|
| Numbers | ||
| 1 | Amoxicillin and Potassium Clavulanate for Injection 300mg. | 115122 |
| 2 | Amoxicillin and Potassium Clavulanate for Injection 600mg. | 23025 |
| 3 | Amoxicillin and Potassium Clavulanate for Injection 1200mg. | 1016385 |
| Sl. | Import Item | Quantity |
| No. | allowed | |
| 1 | AMOXICILLIN SODIUM & CLAVULANATE POTASSIUM STERILE. | 1394.815 kg. |
RA may take appropriate action as per the decision of Norms Committee.
| Case No. 21 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No. & Date: | Approved | |||
| 01/82/050/02298/AM19/ | 05/23/040/00455/AM19/ | No. 0510409259 | ||||
| Dated: 09.01.2019 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
e as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export product | Qty. | Sl.<br>No. | Import items | Qty. |
|---|---|---|---|---|
| CEFTAZIDIME FOR<br>INJECTION 1.0GM. | 84116<br>Numbers | 1 | CEFTAZIDIME FOR<br>INJECTION ( BULK STERILE ) | 100 kg. |
| Case No. 22 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No & Date: | Approved | |||
| 01/82/050/01875/AM19/ | 05/23/040/00163/AM19/ | No. 0510407077 | ||||
| Dated: 04.07.2018 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
| Export Product | Qty. | Sl.<br>No. | Import items | Qty. |
|---|---|---|---|---|
| NOVATRIZOATE<br>60%<br>INJECTION<br>(Diatrizoate<br>Meglumine<br>and<br>Diatrizoate<br>Sodium injection 600mg I /<br>ml)20ml vial. | 16940<br>Numbers | 1 | DIATRIZOIC ACID USP | 265.60 kg. |
| NOVATRIZOATE<br>76%<br>INJECTION<br>(Diatrizoate<br>Meglumine<br>and<br>Diatrizoate<br>Sodium injection 760mg / I<br>ml).20ml vial. | 7800<br>Numbers |
Numbers|1|DIATRIZOIC ACID USP|265.60 kg.| |NOVATRIZOATE<br>76%<br>INJECTION<br>(Diatrizoate<br>Meglumine<br>and<br>Diatrizoate<br>Sodium injection 760mg / I<br>ml).20ml vial.|7800<br>Numbers||||
| Case No. 23 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No. & Date: | Approved | |||
| 01/82/050/01840/AM19/ | 05/23/040/00121/AM19/ | No. 0510406800 | ||||
| Dated: 08.06.2018 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details given below or as applied by firm whichever is lower:
| Export Product | Qty. | Sl. | Import items | Qty. |
|---|---|---|---|---|
| No. | ||||
| NOVATRIZOATE 60% | 1 | DIATRIZOIC ACID USP | 1820.20 kg. | |
| INJECTION (Diatrizoate<br>Meglumine and Diatrizoate<br>Sodium Injection 600 mg I /ml) 20 | 11260<br>Numbers | |||
| ml vial. | ||||
| NOVATRIZOATE 76% | 136220 | |||
| INJECTION (Diatrizoate | Numbers | |||
| Meglumine and Diatrizoate | ||||
| Sodium Injection 760 mg I /ml) 20 | ||||
| ml vial.<br> |
| Case No. 24 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No. & Date: | Approved | |||
| 01/82/050/01885/AM19/ | 05/23/040/00172/AM19/ | No. 0510407158 | ||||
| Dated: 11.07.2018 |
/6||| |||||Dated: 14/06/2023||| |HQ File No.||RLA File No.||Lic. No. & Date:||Approved| |01/82/050/01885/AM19/||05/23/040/00172/AM19/||No. 0510407158||| |||||Dated: 11.07.2018|||
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Sl. | Export product | Qty. | Sl. | Import items | Qty. |
|---|---|---|---|---|---|
| No. | No. | ||||
| 1 | AZTREONAM FOR | 14820 | 1 | AZTREONAM/ARGININE | 16.30 kg. |
| INJECTION USP. 1gm. | Numbers | ( BULK STERILE | |||
| MIXTURE ) |
RA concerned may take further necessary action as per above decision of NC.
| Case No. 25 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No & Date: | Approved | |||
| 01/82/050/01912/AM19/ | 05/23/040/00012/AM19/ | No. 0510406735 | ||||
| Dated: 05.06.2018 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Sl.<br>No. | Export product | Qty. | Sl.<br>No. | Import items | Total Qty. |
|---|---|---|---|---|---|
| 1 | AZTREONAM for<br>Injection USP 500 mg | 10000<br>Numbers | 1 | AZTREONAM/ARGININE<br>( BULK STERILE<br>MIXTURE) | 70.00 kg. |
| 2 | AZTREONAM for<br>Injection USP 1 Gm | 59688<br>Numbers |
---|---|---|---| |1|AZTREONAM for<br>Injection USP 500 mg|10000<br>Numbers|1|AZTREONAM/ARGININE<br>( BULK STERILE<br>MIXTURE)|70.00 kg.| |2|AZTREONAM for<br>Injection USP 1 Gm|59688<br>Numbers||||
RA concerned may take further necessary action as per above decision of NC.
| Case No.26 | Party Name: | Meet No. & Date: | Status: | |||
|---|---|---|---|---|---|---|
| JODAS EXPOIM PVT.LTD | No. NC/3/MEET/Jun/202324/6 | |||||
| Dated: 14/06/2023 | ||||||
| HQ File No. | RLA File No. | Lic. No. & Date: | Approved | |||
| 01/82/050/02026/AM19/ | 05/23/040/00297/AM19/ | No. 0510408024 | ||||
| Dated: 08.10.2018 |
Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to fix the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export Product | Qty. | Sl.<br>No. | Import items | Qty. |
|---|---|---|---|---|
| CEPERON<br>DJ<br>(Cefoperazone<br>powder<br>for<br>Preparation<br>for<br>Solution<br>of<br>Intravenous<br>and<br>Intramuscular<br>Administration<br>1gram. | 43100<br>Numbers | 1 | CEFOPERAZONE<br>SODIUM STERILE USP<br>RELEVANT<br>BULK<br>DRUG. | 91.055 kg. |
| CEPERON<br>DJ<br>(Cefoperazone<br>powder<br>for<br>Preparation<br>for<br>Solution<br>of<br>Intravenous<br>and<br>Intramuscular<br>Administration<br>2gram | 20380<br>Numbers |
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 8019 --apply.